Navigation Links
Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
Date:9/6/2007

DALLAS, Sept. 6 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading U.S. provider of healthcare staffing services, today announced that it has been awarded an exclusive healthcare staffing contract by High Rock Raceway in Spencer, North Carolina. High Rock Raceway is a new development project that includes a two-and-a-quarter-mile road track, 120 track-side condominiums and nearby single-family lots.

High Rock Raceway has partnered with Crdentia to ensure the healthcare program developed for this unique mixed-use property will provide guests, owners, and participants with the highest level of medical care and safety. Under terms of the agreement, Crdentia will be drawing on its expansive database of healthcare professionals to provide registered nurses (RNs) and licensed practical nurses (LPNs) to staff their onsite facility for private non-pro events.

John Kaiser, Crdentia's CEO, commented, "I am very pleased that Crdentia has been awarded this contract. Our commitment to providing high quality healthcare staff of all specialties differentiates us from other major providers and was a key factor in Crdentia being selected to provide staffing services for High Rock Raceway. We believe that this relationship will lead to additional contracts with facilities of this nature across the country."

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 1,500 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health and locum tenens professionals. For more information, visit http://www.crdentia.com.

Forward Looking Statements

Statements contained in this release that are not historical facts are forward-looking statements that involve risks and uncertainties. Among the important factors which could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those discussed in "Risk Factors" in the Company's Forms 10-K, Forms 10-Q, and other filings with the Securities and Exchange Commission. Such risk factors include, but are not limited to, a limited operating history with no earnings; reliance on the Company's management team; the ability to successfully implement the Company's business plan; the ability to continue as a going concern; the ability to fund the Company's business and acquisition strategy; the growth of the temporary healthcare professional staffing business; difficulty in managing operations of acquired businesses; uncertainty in government regulation of the healthcare industry; and limited trading in the public market for the Company's common stock. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:

Crdentia Corp.

Jim TerBeest

Phone: (972) 850-0780

Fax: (972) 392-2722


'/>"/>
SOURCE Crdentia Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
2. Six Towns in India Selected for Eco-City Project
3. Acupuncture provides relief
4. Micro-camera provides new breast imaging technique
5. MicroRNA provides new insight into birth defects
6. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
7. Hormone therapy provides no heart benefit
8. Clothes may provide better protection against sun-related skin problems in children
9. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
10. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
11. Leeches Provide Clues Regarding The Prevention Of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: